Aufdeckung von Arzneimittelrisiken nach der Zulassung-Reference-Cited by-同舟云学术

Aufdeckung von Arzneimittelrisiken nach der Zulassung

Published:2018-07-19 Issue:9 Volume:61 Page:1075-1081
ISSN:1436-9990
Container-title:Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
language:de
Short-container-title:Bundesgesundheitsbl

Author:

Foraita Ronja,Dijkstra Louis,Falkenberg Felix,Garling Marco,Linder Roland,Pflock René,Rizkallah Mariam R.,Schwaninger Markus,Wright Marvin N.,Pigeot Iris

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/article/10.1007/s00103-018-2786-z/fulltext.html

Reference48 articles.

1. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hos-pitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205

2. European Commission (2008) Proposal for a regulation amending, as regards pharmacovigilance of medicinal products for human use. Regulation (EC) No 726/2004. http://ec.europa.eu/health/files/pharmacos/pharmpack_12_2008/pharmacovigilance-ia-vol1_en.pdf . Zugegriffen: 12. Jan. 2018

3. Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 73:759–770

4. Bouvy JC, De Bruin ML, Koopmanschap MA (2015) Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf 38:437–453

5. Stausberg J, Hasford J (2011) Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data. BMC Health Serv Res 11:134

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patientensicherheit im Innovationsfonds – Charakterisierung, Resultate und Bewertung abgeschlossener Projekte: Ergebnisse eines Scoping Reviews;Das Gesundheitswesen;2024-08-15

2. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data;Naunyn-Schmiedeberg's Archives of Pharmacology;2019-12-07